Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes

被引:2
作者
Franco, V
Florena, A
Stella, M
Rizzo, A
Iannitte, E
Quintini, G
Campesi, G
机构
[1] Univ Palermo, Ist Anat & Istol Patol, Policlin, I-90127 Palermo, Italy
[2] Osped V Cervello, Serv Anat Patol, Palermo, Italy
[3] Univ Palermo, Div Ematol, I-90127 Palermo, Italy
关键词
splenic marginal zone lymphoma; splenic lymphoma with villous lymphocytes; bone marrow biopsy; splenectomy;
D O I
10.1002/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Splenic marginal zone cell lymphoma (SMZL) is a low grade B-cell lymphoma in which patients can have circulating villous lymphocytes and can show a peculiar intrasinusoidal bone marrow (BM) infiltration. Splenectomy is the reported treatment of choice for these patients. The objective of this study was to evaluate the effects of splenectomy on patients with BM lymphomatous infiltration. METHODS. BM biopsies of 16 patients with SMZL were studied morphologically and immunohistochemically. In 12 patients, BM biopsies were taken before and after splenectomy. Four patients did not undergo splenectomy, and their BM biopsies were performed with an approximately 1 year interval. RESULTS. BM infiltration ranged from 10% to 40% of overall cellularity and was mostly of the intrasinusoidal type. After splenectomy, Bh? infiltration tended to become frankly nodular and showed an increase in turner burden. Nonsplenectomized patients showed an unmodified picture. CONCLUSIONS. Splenectomy seems to induce important changes in patients with BM infiltration, probably through the lack of microenvironmental factors on circulating cells. These effects suggest reconsidering the role of splenectomy in the treatment of patients with SMZL. (C) 2000 American Cancer Society.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 73 条
[1]  
AHMANN DL, 1966, CANCER-AM CANCER SOC, V19, P461, DOI 10.1002/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO
[2]  
2-X
[3]   Follicular lymphoma with involvement of the splenic marginal zone: A pitfall in the differential diagnosis of splenic marginal zone cell lymphoma [J].
Alkan, S ;
Ross, CW ;
Hanson, CA ;
Schnitzer, B .
HUMAN PATHOLOGY, 1996, 27 (05) :503-506
[4]  
Angelopoulou MK, 1999, SEMIN HEMATOL, V36, P178
[5]  
Arber DA, 1997, MODERN PATHOL, V10, P18
[6]   MALIGNANT LYMPHOPLASMACYTIC LYMPHOMA WITH PROMINENT SPLENOMEGALY (PRIMARY LYMPHOMA OF THE SPLEEN) [J].
AUDOUIN, J ;
DIEBOLD, J ;
SCHVARTZ, H ;
LETOURNEAU, A ;
BERNADOU, A ;
ZITTOUN, R .
JOURNAL OF PATHOLOGY, 1988, 155 (01) :17-33
[7]   CD5+ low-grade marginal zone B-cell lymphomas with localized presentation [J].
Ballesteros, E ;
Osborne, BM ;
Matsushima, AY .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (02) :201-207
[8]  
BOWEN AL, 1999, HAEMATOLOGICA S10, V84, P90
[9]  
Briskin M, 1997, AM J PATHOL, V151, P97
[10]   TRANSLOCATION T(11-14)(Q13-Q32) IN CHRONIC LYMPHOID DISORDERS [J].
BRITOBABAPULLE, V ;
ELLIS, J ;
MATUTES, E ;
OSCIER, D ;
KHOKHAR, T ;
MACLENNAN, K ;
CATOVSKY, D .
GENES CHROMOSOMES & CANCER, 1992, 5 (02) :158-165